Trading & Business Update

AI SummaryClose X

Cambridge Nutritional Sciences plc expects total revenue of £7.0 million for the year ended 31 March 2026, a decrease from £8.3 million in the prior year, primarily due to geopolitical instability impacting Middle East & Asia orders, though underlying revenue growth was approximately 11% excluding these regions. Despite revenue challenges, the company maintained a strong gross profit margin of 67.8% and anticipates an adjusted EBITDA loss of £0.4 million, compared to a £0.4 million profit in 2025, with a net cash balance of £2.6 million.

Disclaimer*

UK 100

Latest directors dealings